Athyrium Capital Management, LP — Q2 2018 13F Holdings

Name: Athyrium Capital Management, LP — 13F Holdings, Q2 2018
Creator: AlphaSMO
License: https://www.sec.gov/forms

CIK: 0001728001

Total reported value

$8.7B

Full holdings list this quarter

#	Ticker	Issuer	Asset Subclass	Weight	Weight Change	Shares Change
1	AEGR 2 08-15-19	Aegerion Pharmaceuticals	Stock-Other	67.68%	—	—
2	PTCT 3 08-15-22	Ptc Therapeutics INC	Stock-Healthcare	30.42%	—	-39.73%
3	HQ8F	Apollo Endosurgery INC	Stock-Other	1.90%	—	—

Position changes disclosed by Athyrium Capital Management, LP for the quarter ending Q2 2018, including ticker, issuer, weight change, shares change, and action
#	Ticker	Issuer	Weight Change	Shares Change	Action
1	AEGR 2 08-15-19	Aegerion Pharmaceuticals	+22.6%	—	Unchanged
2	PTCT 3 08-15-22	Ptc Therapeutics INC	+3.6%	-39.73%	Trim
3	HQ8F	Apollo Endosurgery INC	+0.9%	—	Unchanged
4	✓	Vivus INC	—	EXIT	Sold out